Background The coronavirus disease 2019 (COVID-19) pandemic has impacted many
aspects of ST-segment elevation myocardial infarction (STEMI) care, including timely access …

Background We previously reported high in-hospital mortality for ST-segment elevation
myocardial infarction (STEMI) patients with COVID-19 treated in the early phase of the …

Aims The aim of this study was to assess clinical and prognosis differences in patients with
COVID-19 and STEMI. Methods and results Using a nationwide registry of consecutive …

Objectives To assess changes in characteristics and management among ST‐elevation
myocardial infarction (STEMI) patients with coronavirus disease (COVID‐19) who underwent …

Importance The coronavirus disease 2019 (COVID-19) pandemic has changed health care
delivery worldwide. Although decreases in hospitalization for acute myocardial infarction …

Importance There has been limited research on patients with ST-segment elevation
myocardial infarction (STEMI) and COVID-19. Objective To compare characteristics …

Background We aimed to describe the characteristics and in-hospital outcomes of ST-
segment elevation myocardial infarction (STEMI) patients during the Covid-19 era. Methods …

Background: Coronavirus disease 2019 (COVID-19) pandemic has led to a fast and radical
transformation in social, economic, and healthcare networks. COVID-19 outbreak may thus …

Introduction and objectives The COVID-19 outbreak has had an unclear impact on the
treatment and outcomes of patients with ST-segment elevation myocardial infarction …

Objective To determine whether COVID‐19 may adversely affect outcome of myocardial
infarction (MI) patients in Hong Kong, China. Background The COVID‐19 pandemic has …